Log in to your Inderes Free account to see all free content on this page.
Swedish Orphan Biovitrum
418.40 SEK
+3.72 %
Less than 1K followers
SOBI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+3.72 %
+8.51 %
+23.06 %
+25.72 %
+28.74 %
+49.86 %
+75.64 %
+203.56 %
+776.81 %
Swedish Orphan Biovitrum operates in the pharmaceutical industry and focuses on the development and distribution of medicines for rare diseases. The company's products are aimed at healthcare institutions and patients with specific medical needs. The business is global with a main presence in Europe, North America and Asia. Swedish Orphan Biovitrum was founded in 1939 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
149.54B SEK
Turnover
173.63M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
6.5.
2026
General meeting '26
16.7.
2026
Interim report Q2'26
27.10.
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
Swedish Orphan Biovitrum AB: Sobi publishes Annual and Sustainability Report for 2025
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio